DEUP1, deuterosome assembly protein 1, 159989

N. diseases: 22; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.300 Biomarker disease CTD_human Identification of recurrent fusion genes across multiple cancer types. 30705370 2019
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.300 Biomarker disease CTD_human Identification of recurrent fusion genes across multiple cancer types. 30705370 2019
CUI: C0334588
Disease: Giant Cell Glioblastoma
Giant Cell Glioblastoma
0.300 Biomarker disease CTD_human Identification of recurrent fusion genes across multiple cancer types. 30705370 2019
CUI: C1621958
Disease: Glioblastoma Multiforme
Glioblastoma Multiforme
0.300 Biomarker disease CTD_human Identification of recurrent fusion genes across multiple cancer types. 30705370 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE Coiled-coil domain containing 67 (CCDC67) gene is a tumor suppressor gene that exhibits a significant inhibitory effect on a variety of tumors. 31611958 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 AlteredExpression group BEFREE Analysis of the clinicopathological data revealed that the mRNA and protein expression of DEUP1, and its promoter methylation status, was associated with tumor node metastasis stage and tumor differentiation. 31423198 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 AlteredExpression group BEFREE Lower CCDC67 expression was significantly associated with aggressive tumor behaviors, such as advanced tumor stages and lymph node metastasis, as well as BRAF mutation. 26716505 2016
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE We suggest that CCDC67 is a putative tumor suppressor gene that is silenced in gastric cancers by promoter CpG methylation and that it may play an important role in cell signaling and migration related to tumorigenesis. 22610074 2012
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.020 Biomarker disease BEFREE CCDC67 was verified as a target gene of miR-96-5p in PTC. 31081096 2019
CUI: C0238463
Disease: Papillary thyroid carcinoma
Papillary thyroid carcinoma
0.020 AlteredExpression disease BEFREE The expression of CCDC67, both at mRNA and protein levels, was sharply down-regulated in PTC compared with normal thyroid tissues. 26716505 2016
CUI: C0007115
Disease: Malignant neoplasm of thyroid
Malignant neoplasm of thyroid
0.010 AlteredExpression disease BEFREE In the present study, a thyroid cancer cell line with stable expression of CCDC67 and luciferase reporter genes was generated and identified. 31611958 2019
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.010 PosttranslationalModification phenotype BEFREE Analysis of the clinicopathological data revealed that the mRNA and protein expression of DEUP1, and its promoter methylation status, was associated with tumor node metastasis stage and tumor differentiation. 31423198 2019
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
0.010 AlteredExpression disease BEFREE In the present study, a thyroid cancer cell line with stable expression of CCDC67 and luciferase reporter genes was generated and identified. 31611958 2019
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 PosttranslationalModification disease BEFREE Taken together, the results of the present study suggested that methylation of the DEUP1 promoter maybe an important mechanism for gene inactivation and has a critical role in the occurrence and development of liver cancer. 31423198 2019
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 PosttranslationalModification disease BEFREE Taken together, the results of the present study suggested that methylation of the DEUP1 promoter maybe an important mechanism for gene inactivation and has a critical role in the occurrence and development of liver cancer. 31423198 2019
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 PosttranslationalModification disease BEFREE Taken together, the results of the present study suggested that methylation of the DEUP1 promoter maybe an important mechanism for gene inactivation and has a critical role in the occurrence and development of liver cancer. 31423198 2019
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
0.010 AlteredExpression disease BEFREE In the present study, a thyroid cancer cell line with stable expression of CCDC67 and luciferase reporter genes was generated and identified. 31611958 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.010 AlteredExpression disease BEFREE The results showed that the mRNA and protein expression of DEUP1 in adjacent non-tumor tissues was significantly increased compared with in the HCC tissues. 31423198 2019
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 Biomarker disease BEFREE Specifically, we targeted the breakpoints of TMEM135-CCDC67 and MAN2A1-FER fusions in human prostate cancer or hepatocellular carcinoma cells in vitro and in mouse xenografts. 28459452 2017
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 Biomarker disease BEFREE Specifically, we targeted the breakpoints of TMEM135-CCDC67 and MAN2A1-FER fusions in human prostate cancer or hepatocellular carcinoma cells in vitro and in mouse xenografts. 28459452 2017
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 Biomarker group BEFREE These results are consistent with CCDC67 being a novel and impaired tumor suppressor gene in PTC, providing important prognostic and therapeutic implications for this cancer. 26716505 2016
Secondary malignant neoplasm of lymph node
0.010 AlteredExpression disease BEFREE Lower CCDC67 expression was significantly associated with aggressive tumor behaviors, such as advanced tumor stages and lymph node metastasis, as well as BRAF mutation. 26716505 2016
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.010 Biomarker group BEFREE These results are consistent with CCDC67 being a novel and impaired tumor suppressor gene in PTC, providing important prognostic and therapeutic implications for this cancer. 26716505 2016
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.010 GeneticVariation disease BEFREE Epigenetic alteration of CCDC67 and its tumor suppressor function in gastric cancer. 22610074 2012
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 PosttranslationalModification phenotype BEFREE We suggest that CCDC67 is a putative tumor suppressor gene that is silenced in gastric cancers by promoter CpG methylation and that it may play an important role in cell signaling and migration related to tumorigenesis. 22610074 2012